Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Median Technologies’ EUR 21.6 million Follow-On Offering & Convertible Bonds Issuance

Bryan, Garnier & Co acts as Sole Financial Advisor to PhysioAssist on its $45m Sale to Inogen

Bryan, Garnier & Co acts as Sole Financial Advisor to Physidia and its shareholders, a leading European renal care medtech company providing home haemodialysis solutions, on the sale of a majority stake to Columna Capital

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Medincell’s EUR 25 million Follow-on Offering

Bryan, Garnier & Co acts as Financial Advisor & Placement Agent on Abivax’s EUR 130 million Cross-over Financing

Bryan, Garnier & Co acts as Sole Financial Advisor to Selfapy, one of the leading providers in digital therapeutics for mental health disorders in Germany, on its growth financing from strategic investor Medice Arzneimittel and existing shareholders

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ Nasdaq Stockholm SEK 210 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Bookrunner on Oncodesign Precision Medicine’s EUR 8 million Follow-on Offering & IPO on Euronext Growth Paris

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on the acquisition of the Machine & Perfusion division from Avionord S.r.l.

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Nicox’ Euronext Paris EUR 10 million Follow-on Offering & Warrants issuance

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq and Euronext Paris EUR 102.9 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Abivax’s EUR 49 million Cross-over Financing

Bryan, Garnier & Co acts as Sole Financial Advisor to Ganymed Robotics, a developer of computer vision software and robotics technologies for orthopedic surgeons, on its first €21 million closing of its oversubscribed Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor to Oncodesign on the sale of its CRO activities to Elyan Partners for €100m and the concomitant spin-off of its Biotech/AI activities

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on GeNeuro EUR 7.7 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Grundium Oy on the sale of a majority stake to EW Healthcare Partners

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }